Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Biologic lifelines
Washington - Five new biologic drugs for psoriasis offer useful alternatives when the standard therapies cannot be used, according to Henry W. Lim, M.D. Dr. Lim focused on the five biologics in his summary of the most important recent developments in medical dermatology for the American Academy of Dermatology annual meeting.
Recent Videos
Related Content
